<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

CURRENT PARTICIPANTS

 

DOWNLOAD THE PROSPECTUS
REQUEST AN INVITATION
Julian Gilbert

Julian Gilbert

CEO
Acacia Pharma
Mary Kerr

Mary Kerr

CEO
NeRRe Therapeutics
Mark Swindells

Mark Swindells

COO
Exscientia
Richard Penny

Richard Penny

Fund Manager
Crux Asset Management
Stephen Yang

Stephen Yang

CIO
Curam Capital
Jonathan Tobin

Jonathan Tobin

Investment Director
Arix Bioscience Plc
Eliot Forster

Eliot Forster

Former CEO
Immunocore
Edwin Moses

Edwin Moses

CEO
Ablynx
Khatereh Ahmadi

Khatereh Ahmadi

Executive Director, Oncology Search and Evaluation Lead, European Hub
MSD
Richard Vellacott

Richard Vellacott

Interim CEO
Horizon Discovery Group
Cliff Holloway

Cliff Holloway

CEO
Scancell Holdings
Dayle Hogg

Dayle Hogg

COO
GammaDelta Therapeutics
Gary Green

Gary Green

Partner
CMS
Sarah Hanson

Sarah Hanson

Partner
CMS
 Duncan Peyton, CEO, 4D Pharma

Duncan Peyton

CEO, 4D Pharma
4D Pharma
Satu Vainikka, CEO, Valirx

Satu Vainikka

CEO
Valirx